Total tau protein, phosphorylated tau (181p) protein, β-amyloid 1-42, and β-amyloid1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 2, 2006, Pages 192-195

  Mollenhauer, Brit ^a,b   Bibl, Mirko ^b   Wiltfang, Jens ^c   Steinacker, Petra ^b   Ciesielczyk, Barbara ^b   Neubert, Karin ^b   Trenkwalder, Claudia ^b   Otto, Markus ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

amyloid; Alzheimer's disease; Cerebrospinal fluid; Dementia with Lewy bodies; Laboratory marker; Phosphorylated tau protein; Total tau protein

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS;

EID: 32544446902     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2006.035     Document Type: Article

References (14)

1. McKeith IG, Galasko D, Kosaka, Perry EK, Dickson DW, Hansen L, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy-bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
2. 1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. J Am Med Assoc 2003;289:2094-103.
3. Gomez-Tostosa E, Gonzales I, Fanjul S, Sainz MJ, Cantarero S, Cemillan C, et al. Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease. Arch Neurol 2003;60:1218-22.
4. Tschampa H, Schulz-Schaeffer WJ, Wiltfang J, Poser S, Otto M, Neumann N, et al. Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies. Neurology 2001;56:576.
5. Mollenhauer B, Cepek L, Bibl M, Wiltfang J, Schulz-Schaeffer WJ, Ciesielczyk B, et al. Tau protein, Aβ42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dement Geriatr Cogn Disord 2005;19:164-70.
6. Mollenhauer B, Bibl M, Trenkwalder C, Stiens G, Cepek L, Steinacker P, et al. Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease. J Neural Transm 2005; 112:933-48.
7. Harrington CR, Perry RH, Perry EK, Hurt J, McKeith IG, Roth M, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994;5:215-22.
8. Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F, et al. CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. Neurol Sci 2001;22:77-8.
9. Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, et al. Differential diagnosis of Alzheimer's disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 2002;59: 1267-72.
10. (1-42) and tau levels in CSF. Neurology 1999;52:1555-62.
11. Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, et al. Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau. Neurobiol Aging 2004;25:273-81.
12. 1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol 1998;44:17-26.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-44.
14. Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, et al. Measurement of phosphorylated tau epitopes in differential diagnosis of Alzheimer's disease. Arch Gen Psychiatry 2004;61:95-102.